Philip Wagenheim - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Philip Wagenheim has filed 1 SEC Form 4 filing across 1 company in the last 90 days - selling. Lifetime open-market sales: $1.34M.
Profile
Philip Wagenheim is a beneficial owner of more than 10% of Immunome Inc. (IMNM), as disclosed in SEC ownership filings. SEC records also connect Wagenheim to Swarmer, Inc (SWMR). Wagenheim has reported 3 insider filings with the SEC since 2026. The most recent filing was in June 2026.
| Role | Insider |
|---|---|
| Notability | 36/100 |
Board memberships
- Immunome Inc.
- Swarmer, Inc
Reported roles
- Director
Trading Pattern
InsiderAlpha's records for Philip Wagenheim go back to 2026: 3 primary Form 4 filings, an average of 3.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Philip Wagenheim has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Insider at Immunome Inc. (IMNM) - 2 filings, 2026
- Director, 10% Owner at Swarmer, Inc (SWMR) - 1 filing, 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-24 | IMNM | Immunome Inc. | S - Open-market sale | 28.2K | $20.65 | $582K |
| 2026-03-24 | IMNM | Immunome Inc. | S - Open-market sale | 36.8K | $20.47 | $753K |
| 2026-03-18 | SWMR | Swarmer, Inc | J - Other acquisition / disposition | 1.12M | - |
Companies - Last 90 Days
- Immunome Inc. (IMNM) - 1 filing, last 2026-06-12
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Philip Wagenheim has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Isaac Barchas - $6.81M of IMNM open-market activity in the last 12 months
- Max Rosett - $2.52M of IMNM open-market activity in the last 12 months
- Robert Lechleider - $2.34M of IMNM open-market activity in the last 12 months
- Jean Jacques Bienaime - $555K of IMNM open-market activity in the last 12 months
- Clay B. Siegall - $501K of IMNM open-market activity in the last 12 months
- Jack Higgins - $204K of IMNM open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Gjorgi Popstefanov
- Adam D. Portnoy
- David Portnoy
- PRUDENTIAL FINANCIAL INC
- PRUDENTIAL INSURANCE CO OF AMERICA
- PUBLIC INVESTMENT FUND
- Qatar Investment Authority
- R01 Fund LP
Frequently Asked Questions
Who is Philip Wagenheim?
Philip Wagenheim is a beneficial owner of more than 10% of Immunome Inc. (IMNM), as disclosed in SEC ownership filings. SEC records also connect Wagenheim to Swarmer, Inc (SWMR). Wagenheim has reported 3 insider filings with the SEC since 2026. The most recent filing was in June 2026.…
How many SEC Form 4 filings has Philip Wagenheim submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Philip Wagenheim been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($1.34M) across all tracked filings.
Where can I see all of Philip Wagenheim's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Philip Wagenheim profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.